Xue et al. observed that compared with healthy controls, the expression levels of IL21 and IL21R were decreased in the serum and lung tissue of lung cancer patients, suggesting IL21R as a tumour suppressor in the development of non-small cell lung cancer [36]. The gene discussed is IL21R; the disease is lung carcinoma.